Data Patterns (India) Limited (BOM:543428)
India · Delayed Price · Currency is INR 2,550.30
-83.95 (-3.19%)
At close: Aug 1, 2025
Intra-Cellular Therapies Revenue
In the fiscal year ending March 31, 2025, Data Patterns (India) had annual revenue of 7.08B INR with 36.27% growth. Data Patterns (India) had revenue of 3.96B in the quarter ending March 31, 2025, with 117.35% growth.
Revenue
7.08B
Revenue Growth
+36.27%
P/S Ratio
20.16
Revenue / Employee
5.39M
Employees
1,313
Market Cap
142.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 7.08B | 1.89B | 36.27% |
| Mar 31, 2024 | 5.20B | 663.50M | 14.63% |
| Mar 31, 2023 | 4.53B | 1.43B | 45.87% |
| Mar 31, 2022 | 3.11B | 869.00M | 38.80% |
| Mar 31, 2021 | 2.24B | 678.52M | 43.47% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |